Human gene therapy and slippery slope arguments
McGleenan T.
School of Law,
Queen's University of Belfast
J Med Ethics. 1995 Dec;21(6):350-5.


Any suggestion of altering the genetic makeup of human beings through gene therapy is quite likely to provoke a response involving some reference to a 'slippery slope'. In this article the author examines the topography of two different types of slippery slope argument, the logical slippery slope and the rhetorical slippery slope argument. The logical form of the argument suggests that if we permit somatic cell gene therapy then we are committed to accepting germ line gene therapy in the future because there is no logically sustainable distinction between them. The rhetorical form posits that allowing somatic cell therapy now will be taking the first step on a slippery slope which will ultimately lead to the type of genocide perpetrated by the Nazis. The author tests the validity of these lines of argument against the facts of human gene therapy and concludes that because of their dependence on probabilities that cannot be empirically proven they should be largely disregarded in the much more important debate on moral line-drawing in gene therapy.
Liberal Eugenics
Evolutionary ethics
'Artificial' evolution
'Liberal eugenics' (PDF)
Germline genetic engineering
Congenital insensitivity to pain
Artificial insemination and eugenics
Gene therapy and performance enhancement
An overview of Autism and Asperger syndrome
Transhumanism (H+): toward a Brave New World?
'Slippery slope' arguments, persons of 'lesser value', and the Holocaust

and further reading

BLTC Research
Utopian Surgery?
The Good Drug Guide
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
MDMA: Utopian Pharmacology
Critique of Huxley's Brave New World